Ovarian tumors - Globe Thesis

Keyword [Ovarian tumors] Result: 181 - 200 \| Page: 10 of 10
181.	A Comparative Study Of The Effiency Of Different Chemotherapy Regimens For Advanced Ovarian Cancer After R0 Operation
182.	Clinical Analysis Of 13 Cases Of Pregnancy Complicated With Borderline Ovarian Tumors
183.	Comparative Analysis Of ROMA And CPH-I In Differentiating Of Ovarian Tumors
184.	Clinical Analysis Of Borderline Ovarian Tumors And The Application Of Ovarian Tumor Extirpation In Early Borderline Ovarian Tumors
185.	The Expression And Correlational Research Of SATB1 And DNMT1 On Ovarian Cancer
186.	Study On Quantitative Analysis Of IVIM-DWI In Ovarian Tumors
187.	Relationship Between Pelvic Inflammatory Diseases And The Risk Of Ovarian Tumors:A Meta Analysis
188.	Analysis Of Prognostic Factors In Patients With Borderline Ovarian Tumors
189.	The Clinical Value Of Combined Detection Of CA125,D-dimer,PLT And FIB In The Diagnosis Of Ovarian Tumors
190.	Expression And Significance Of EB1 And Aurora-B In Epithelial Ovarian Tumors
191.	The Value Of IVIM And Quantitative DCE-MRI In Differentiating Epithelial Ovarian Tumors And Their Correlation With Ki67
192.	The Value Of MRI Combined With Serum Tumor Markers In Preoperative Differential Diagnosis Of Mucinous Ovarian Tumors
193.	The Diagnostic Value Of CEUS Combined With CA125 And HE4 In Ovarian Tumors
194.	Analysis Of Factors Influencing Recurrence Of Patients With Borderline Ovarian Tumors And Postoperative Recurrence And Pregnancy With Fertility Sparing-surgery
195.	Clinical Analysis Of 253 Patients With Borderline Ovarian Tumors
196.	The Clinical Value Of Serum CA125,HE4 And ROMA In The Diagnosis Of Benign And Malignant Ovarian Tumors
197.	Expression Of HE4,KIF2A In Epithelial Ovarian Tumors And Its Relationship With Clinical Pathology
198.	Analysis Of Related Factors Of Postoperative Recurrence Of Borderline Ovarian Tumors
199.	Analysis Of Clinical Manifestations And Prognostic Factors In 96 Cases Of Borderline Ovarian Tumors
200.	A Preliminary Study Of Malignant Risk Assessment Systems For Postmenopausal Ovarian Tumors
<<First <Prev Next> Last>> Jump to